- Home
- KGS vs KYMR Comparison
KGS vs KYMR Comparison
Compare KGS & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KGS | KYMR |
|---|---|---|
| Founded | 2011 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7B | 7.1B |
| IPO Year | 2023 | 2020 |
Fundamental Metrics
Financial Performance| Metric | KGS | KYMR |
|---|---|---|
| Price | $67.43 | $73.25 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 26 |
| Target Price | $57.17 | ★ $107.72 |
| AVG Volume (30 Days) | ★ 2.0M | 444.8K |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | ★ 2.93% | N/A |
| EPS Growth | ★ 58.93 | N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $1,308,100,000.00 | $39,211,000.00 |
| Revenue This Year | $12.30 | $10.61 |
| Revenue Next Year | $7.96 | $8.17 |
| P/E Ratio | $336.75 | ★ N/A |
| Revenue Growth | ★ 12.83 | N/A |
| 52 Week Low | $30.06 | $36.88 |
| 52 Week High | $77.68 | $103.00 |
Technical Indicators
Market Signals| Indicator | KGS | KYMR |
|---|---|---|
| Relative Strength Index (RSI) | 45.81 | 36.40 |
| Support Level | $33.80 | $73.31 |
| Resistance Level | $77.18 | $77.93 |
| Average True Range (ATR) | 2.26 | 3.05 |
| MACD | -1.16 | -0.83 |
| Stochastic Oscillator | 22.40 | 30.95 |
Price Performance
Historical ComparisonAbout KGS Kodiak Gas Services Inc.
Kodiak Gas Services Inc is an operator of contract compression infrastructure in the United States. The company manages its business through two operating segments: Contract Services and Other Services. Contract Services consists of operating company-owned and customer-owned compression, gas treating, and cooling infrastructure, pursuant to fixed-revenue contracts to enable the production and gathering of natural gas and oil. Other Services consist of a full range of contract services to support the ancillary needs of customers, including station construction, maintenance and overhaul, freight and crane charges, and other time and material-based offerings. Maximum revenue for the company is generated from its Contract Services segment.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.